KRAS and familial pancreatic carcinoma: In this study, the antiproliferative and antimetastatic activities of KV, a bisbenzylisoquinoline alkaloid, were elucidated in KRAS-mutated oxaliplatin-resistant pancreatic cancer cells (oxaliplatin-resistant AsPC-1 cells).